After reconstitution, keep refrigerated and use within a short window under sterile conditions
Wickham, S., West, M
In some embodiments, the otic formulation or composition comprises between about 0.10% to about 5% by weight of the therapeutic agent, or pharmaceutically acceptable prodrug or salt thereof
Octane, in contrast, remains in the liquid phase all the way up to 128 o C, due to the increased influence of attractive London forces, made possible by the larger surface area of the individual molecules
The practical upper limit for nasal peptide delivery is estimated to be somewhere around 25-30 kDa
Covers origins, mechanism of action, tendon and gut healing research, angiogenesis, and CNS research findings